• Using the Global Burden of Disease database to inform priority setting
• Using the Global Burden of Disease database to inform priority setting decisions
• Using the GRADE approach to develop guidelines in low income countries: views of guideline panelists in Kenya
• Using the GRADE approach to network meta-analysis
• Using the Medical Research Council framework for randomised controlled trials (RCTs) of complex interventions to identify and develop strategies to promote effective professional practice
• Using the new Cochrane Style Guide
• Using the new online GRADEpro to create 'Summary of findings' tables
• Using the new online GRADEpro to create summary of findings tables ***in computer lab; no need for personal laptops
• Using the new online software, GDT, to create 'Summary of findings' tables
• Using the online GRADEpro to create 'Summary of findings' tables
• Using the online GRADEpro to create 'Summary of findings' tables (in Spanish)
• Using the online GRADEpro to create 'Summary of findings’ tables and patient-friendly tools
• Using the results of a qualitative systematic review for quantitative instrument validation
• Using the results of systematic reviews, overviews of systematic reviews, and network meta-analyses to inform clinical practice guideline recommendations
• Using the RobotAnalyst text-mining application to boost efficiency of literature screening: experience from a systematic review in health services research
• Using the TRANSFER framework for assessing transferability of review findings – a case study
• Using the Vote Cards to Encourage Active Participation and to Improve Critical Appraisal Skills in Evidence-Based Medicine Journal Clubs
• Using theory of change to assess impact of knowledge translation initiatives
• Using Theory of Change to Assess Impact of Knowledge Translation Initiatives
• Using theory to guide synthesis of qualitative research: why, how and what would this mean for me?
• Using theory to inform evidence synthesis : a case study of school accountability systematic review in developing countries
• Using workflow reports in Archie to evaluate and improve Cochrane Review Group editorial processes
• Using workflows in Archie
• Utilising Cochrane reviews in clinical guideline development
• Utility of machine learning to identify research for updating a systematic map of evaluations of public health interventions within community pharmacies
• Utilization analysis of Chinese abstract of the Cochrane Database of Systematic Reviews in three university hospitals
• Utilization of online database for medical information: a nationwide survey of physicians at regional hospitals in Taiwan
• Utilization of trial registry records and randomized controlled trial study protocols in Cochrane systematic reviews of interventions: a content analysis
• Utilization, impact and barriers to use the Cochrane Database of Systematic Reviews: survey on Chilean post graduate medical students
• Utilizing a logic model framework to evaluate patient navigation interventions on colorectal cancer screening time to diagnostic follow-up care: a study protocol
• Utilizing evidence of Cochrane in decision making by policy makers: Gaps needs to be filled
• Vaccine efficacy/effectiveness: Calculation, visualization, and interpretation based on an exemplary systematic review on COVID-19 vaccination in children
• Validating Cochrane Neonatal’s standard search databases: Is it okay to stop searching Embase?
• Validating prognosis search filters using relative recall based on prognosis systematic reviews
• Validation and application of a systematic review and narrative synthesis within mental health services research
• Validation of a PubMed search filter for identifying studies including children
• Validation of a quality assessment checklist for case series studies
• Validation of a questionnaire to measure people’s ability to assess claims about treatment effects in Spanish
• Validation of five search filters for retrieving clinical guidelines showed low precision
• Validation of the EBP process assessment scale (EBPPAS): a scale to measure practitioners views about evidence-based practice
• Validation of the Spanish version of the Risk of Bias in Systematic Reviews (ROBIS) tool
• Validity of Health Technology Assessements(HTA)
• Validity of patient-reported data collected through mobile application in a first paediatric at-home study
• Value of infographics in communicating Cochrane plain language summaries
• Values and preferences in asthma patients for health care decision making: a systematic literature review.
• Variability and completeness of outcome reporting in studies for low back pain rehabilitation interventions: a survey of trials included in Cochrane Reviews
• Variability of outcome measures among trials of topical Chinese herbal medicines for musculoskeletal injuries
• Variation among experienced reviewers in the interpretation of the evidence from randomized controlled trials (RCTs)
• Variation in defining and reporting chronic postsurgical pain following breast cancer surgery: a systematic survey of 188 observational studies
• Variation in definition and measurement of primary outcomes in Cochrane systematic reviews of pharmacological treatment of stable COPD
• Variation in outcome measure usage across Cochrane Systematic Reviews related to three common eye conditions
• VARIATION OF WORK PARTICIPATION OUTCOMES AND MEASUREMENT METHODS IN TRIALS
• Variations between trials of the effect of chemotherapy: an exploratory analysis of the meta-analysis of chemotherapy in head and neck carcinoma data
• Variations in approaches to mixed methods review: a case study
• Verification of conflicts of interest disclosures in health research: a conceptual analysis
• Verification of the accuracy and completeness of disclosures of Conflict of Interest in the medical literature: a systematic survey
• Videos to improve Portuguese translations of Cochrane abstracts and Plain language summaries: preliminary results of the Brazilian Quality Project
• Views towards publishing protocols for systematic reviews as peer-reviewed articles: an international survey of authors of non-Cochrane systematic reviews
• Vinca alkaloid containing regimen for advanced breast cancer
• VIP (Very Integrated Program) Project on alcohol and drug abusers in Southern Sweden - RCT of efficacy of the adding the health promotion and rehabilitation for treatment of alcohol and drug abusers
• Virtual reality environments (VRE) for pre-and post- registration health professional education
• Vision 2020, The right to sight
• Visitor-determined website improvement: combining survey and log results on Cochrane.org
• Visual summaries to increase accessibility and understanding of Cochrane Review evidence
• Visual-storytelling tools for evidence translation and use
• Visualisation study on research in the field of public health published in the Cochrane Library
• Visualising systematic review search strategies to assist information specialists
• Visualization analysis of the research front and hot domains of based-evidence research in the Global Evidence Summit
• Visualization of evidence based medicine development
• Vitamin A given to children with measles - Does dose make a difference?
• Vitamin D analogues in the prevention of axial and appendicular fractures: report of a meta-analysis
• Voices of Cochrane authors: a review of Cochrane podcasts from 2014 to 2018
• Volatile anesthetics versus total intravenous anesthesia in patients undergoing coronary artery bypass grafting: An updated meta-analysis and trial sequential analysis of randomized controlled trials
• Volunteer initiative in war-torn Syria to translate Cochrane Blogshots
• Waiting list may be a ‘nocebo’ condition in psychotherapy trials
• Wales COVID-19 Evidence Centre: a bespoke evidence review process engaging stakeholders for supporting time-sensitive policy and clinical decision-making
• Warnings for serious adverse events in drug labelling: Are same-class drugs treated the same?
• Waste in research? Exploring overlaps in systematic reviews on exercise for depression in children and adolescents
• Ways to ensure evidence-based clinical practice guidelines are of high quality
• Web searching for systematic reviews: how to develop the current guidance on methods and reporting standards
• Web-based training packages to enhance evidence-informed policy-making for health in the Eastern Mediterranean Region
• Web-based virtual collaborative workspace to support development of systematic reviews and clinical practice guidelines
• WeCancer: a self-tracking platform for both oncology patients and physicians to allow standardised treatment
• Weight of evidence and reliability of meta-analysis
• Were meta-analyses of etiological studies of high methodological qualities?
• Were the outcomes reported in systematic reviews stated in protocols? A systematic review
• What action when there is no evidence?
• What are the barriers preventing authors from reading written instructions?
• What are the barriers to, and facilitators of, implementing and receiving MHPSS programmes delivered to populations affected by humanitarian emergencies? A qualitative evidence synthesis
• What are the characteristics of clinical practice guidelines for the treatment of depression?
• What are the characteristics of good reviews of adverse effects? A qualitative exploration
• What are the opportunities for co-production in living evidence synthesis?
• What are the reporting and methodological qualities of network meta-analysis?
• What Blocks the Production of Cochrane Reviews in China?
• What can a trial registry do for you? The Pan African Clinical Trials Registry: a resource for Cochrane authors
• What can evidence-based education and healthcare learn from each other?
• What can The Cochrane Collaboration do to support people living in developing countries? A survey
• What can we change through social media? Learning from sharing experience and evidence on sexual problems
• What can we learn from Chinese randomized controlled trials? A systematic review of Chinese venlafaxine studies
• What certainty can there be on how much treatments Work: empirical insight from recursive cumulative meta-analyses
• What characteristics classify 'experience' with data abstraction?
• What could be expected from systematic reviews on individual patient data? Examples from hypertension treatment
• What determinants of public health research activity contextualise embedded researcher roles? A qualitative investigation in English local government
• What difference does patient and public involvement make to evidence synthesis?
• What dissemination bias really means and how we can tackle it
• What do authors of Cochrane reviews mean by the term 'older' people?
• What do clinicians understand and how do they interpret results from network meta-analysis and the way they are presented?
• What do Cochrane Systematic Reviews say about conservative and surgical treatment interventions in the treatment of rotator cuff disease?
• What do Cochrane Systematic Reviews say about telemedicine on healthcare?
• What do consumers think should be reported about consumer involvement in research?
• What do funders do to minimize waste in research?
• What do patients and physicians want at the point of care? Preliminary surveys in China
• What do patients and their caregivers value on self-management interventions for chronic conditions? A scoping review of systematic reviews for the COMPAR-EU project
• What do test-treat trials measure?
• What do we know about interpretation and application of test accuracy measures?
• What do you mean there's no mean?
• What do you mean? Collated consumer feedback on Cochrane reviews and protocols on topics in pregnancy
• What does good co-production in evidence synthesis look and feel like?
• What does it mean? Plain language summaries of advice on health technologies
• What evidence is available and what is required, in humanitarian assistance?
• What factors predict original research citation rates? Analysis of media reports, editorials, guidelines and reviews of Rituximab for non-Hodgkin's lymphoma (NHL; 1997-2003)
• What German hospital pharmacists want to know: cross-sectional survey on information behaviour and information needs
• What guidance is available for researchers conducting overviews of reviews? a scoping review and qualitative metasummary
• What happens after the HTA analysis? A follow-up study of regional HTA reports conducted 2007-2015
• What Happens When the Evidence Is Not There?: The Contribution of Systematic Review Methodology to Future Research
• What happens when you take the Cochrane methodology and apply it to non-clinical literature?
• What if EPOC reviews only included studies from MEDLINE?
• What information resources are searched to prepare systematic reviews of economic evaluations?
• What is a meta-epidemiological study? Analysis of published literature showed heterogeneous study designs and definitions
• What is a rapid review?
• What is being published? A word cloud of titles from The Cochrane Library
• What Is Going on in the Future For Evidence-Informed Health Policy-Making?
• What is the current situation of the published N-of-1 trial?
• What is the definition of "evidence" in Health Sciences?
• What is the effect of phasing out long-chain per- and polyfluoroalkyl substances on the concentrations of perfluoroalkyl acids and their precursors in the environment?
• What is the evidence for collaborative approaches between service users and community mental health nurses to identify and support survivors of Domestic Violence and Abuse (DVA) using a rapid review approach?
• What is the experience of family carers of patient with dementia living in community of South Korea?
• What is the influence of randomization sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological study
• What is the level of expertise of ChatGPT in the domain of systematic reviews and meta-analysis?
• What is the methodological quality and transparency of depression clinical practice guidelines?
• What is the most appropriate knowledge synthesismethod to conduct a review? A scoping review
• What is the most efficient de-duplication software for use in systematic reviews?
• What is the nature and magnitude of inappropriate healthcare services in Canada? A Systematic Review
• What is the probability of discovering breakthrough interventions in industry versus publicly sponsored randomized controlled trials
• What is the probability that results of meta-analyses will favor innovative treatments?
• What is the role of public trials registers in Cochrane Systematic Reviews?
• What is the role of scientific evidence in decisions to adopt complex innovations? A multiple case study in cancer care
• What is the study design?
• What is the test’s accuracy in my practice population Tailored meta-analysis provides a plausible estimate
• What kind of evidence can be found in incident reporting systems? Systematic evaluation of incident reports to identify risks using syringe pumps
• What measures of accuracy should we present in DTA reviews?
• What modifications are made in studies reviewed by the United States Food and Drug Administration for medical device approval?
• What next for Cochrane in systematic reviews of prognosis?
• What obstacles do general practitioners face in implementing guidelines for the management of depression?
• What place do consumers and an international network structure have within The Cochrane Collaboration? A formal review
• What systematic reviews gain when they include qualitative research: a systematic review of qualitative work on workplace-based return to work practices
• What to do if the results of conventional pairwise meta-analysis and network meta-analysis are contradictory? An example from a systematic review on the effects of antipsychotics in treatment-resistant schizophrenia
• What to do with non 2x2 data from a diagnostic systematic review? An example from a review on identifying the seizure focus in patients with epilepsy
• What to edit and when in Cochrane reviews. Where to start and when to stop!
• What useful information does a search summary table provide: a case study from a mixed methods systematic review
• What we do in the shadows: Interviews with methodologists on synthesis methods when meta-analysis is not possible for all studies
• What we don't know about evidence and medical practice: Issues raised by Project ImpACT and lessons from the impact literature
• What we know we don’t know: identifying thera­peutic uncertainties from systematic reviews
• What we’re learning about evidence-informed policymaking: Researchers’ perspectives on advocating for evidence in Africa
• What will the first impact factor of The Cochrane Library tell us
• What will the second impact factor tell us about The Cochrane Library and its systematic reviews?
• What Works Centres – collaboration across health, social care, educational achievement, crime, early intervention, economic growth, ageing better and wellbeing
• What works, for whom and when: the rational for and outcomes from a realist review of advocacy for women experiencing partner abuse
• What's unique about conducting research with adolescents in low- and middle-income countries: Introducing a new methodological series
• What’s in ‘Dr Cochrane’ for family physicians? Evaluation of an online Cochrane Learning programme with the Information Assessment Method (IAM)
• What’s in it and how do users find it?—challenges of knowledge transfer through specialised registers of health promotion effectiveness
• What’s more important - timeliness or accuracy of results in providing evidence? Preliminary results on a research program on rapid reviews
• What’s the point of evaluating effectiveness? Perspectives from a low income setting
• What’s the problem in involving consumers in Cochrane review groups: the experiences of the consumer representative on the Monitoring and Registration Group
• What’s the story?: publicity, global media coverage and author experience
• What(ch) evidence! Drawing on the actor-network theory for an exploration of the dynamic struggle of the Cochrane Collaboration to build bridges between research results and clinical practice
• When and how to update systematic reviews: a methodological systematic review
• When can research conducted elsewhere be useful here? Perceptions of local applicability and transferability
• When can we trust ‘early’ statistically significant treatment effect estimates in cumulative cardiology meta-analyses? – a simulation study
• When clinical practice does not follow the evidence: physician's recommendation of mammography
• When clinical practice does not follow the evidence: physician's recommendation of mammography
• When do indirect and mixed treatment comparisons result in invalid findings? A graphical explanation
• When engaging with stakeholders is tricky: effective and ethical stakeholder engagement in reviews on sensitive, challenging or controversial topics
• When it rains: synthesizing umbrella reviews of educational interventions
• When lack of evidence informs policy and the public debate: experiences from a systematic review on shared physical custody
• When methodologies conflict: developing tools to compare and select appropriate methodologies for conducting, and appraising evidence from systematic reviews
• When rating gets tough - coping with difficult situations when using the new risk of bias assessment tool
• When should an effective treatment be recommended for use? Quantitative derivation of the threshold NNT
• When should potentially false research findings be tolerated?
• When should systematic reviews be replicated, and when is it wasteful?
• When should systematic reviews be replicated, and when is it wasteful? An analysis of reasons for discordance among overlapping systematic reviews
• When should systematic reviews of effects restrict studies to those conducted in low- and middle-income countries: A proposal?
• When there is no evidence - an RCT for treatment of otitis media with asymptomatic effusion (OME) in Aboriginal infants
• When to call upon a working group of experts to produce recommendations using an Accelerated Developed Guidelines (ADG) method?
• When treatments can be combined: example of infection prophylaxis in cancer patients
• When you conduct a systematic review about drug safety, you will run into these issues
• When, why and how to conduct a Cochrane overview of reviews
• When, why, and how to conduct a Cochrane overview of reviews
• Where and how to find data on safety: What do systematic reviews of complementary therapies tell us?
• Where do completed trials come from?